1. Antenatal dexamethasone retarded fetal long bones growth and development by down-regulating of insulin-like growth factor 1 signaling in fetal rats. (7th January 2022) Authors: Qiu, Junlan; Fan, Xiaorong; Ding, Hongmei; Zhao, Meng; Xu, Ting; Lei, Jiahui; Ji, Bingyu; Zhuang, Zhixiang; Gao, Qinqin Journal: Human & experimental toxicology Issue: Volume 41(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer. Issue 9 (10th September 2020) Authors: Wang, Qiaoyun; Zhao, Shuai; Gan, Lei; Zhuang, Zhixiang Journal: Bioscience reports Issue: Volume 40:Issue 9(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting. (17th November 2018) Authors: Ma, Junzhe; Zhuang, Huiru; Zhuang, Zhixiang; Lu, Yufeng; Xia, Rui; Gan, Lei; Wu, Yuantao Journal: Artificial cells, nanomedicine, and biotechnology Issue: Volume 46:Number 8(2018) Page Start: 1864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial. Issue 2 (15th October 2020) Authors: Song, Yan; Li, Ning; Li, Qun; Liang, Xinjun; Zhang, Shu; Fan, Qingxia; Yin, Xianli; Zhuang, Zhixiang; Liu, Yunpeng; Zhang, Jingdong; Kou, Xiaoge; Zhong, Haijun; Wang, Xiaofei; Dou, Yiwei; Huang, Jing Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗